BACKGROUND: The purpose of this single-blinded, randomized, controlled trial was to compare the analgesic efficacy of intra-articular injections of bupivacaine or ropivacaine with that of no injection for postoperative pain control after the operative treatment of supracondylar humeral fractures in a pediatric population. METHODS:Subjects (n=124) were randomized to treatment with 0.25% bupivacaine (Group B) (n=42), 0.20% ropivacaine (Group R) (n=39), or no injection (Group C) (n=43). The opioid doses and the times of administration as well as child-reported pain severity (Faces Pain Scale-Revised) and parent-reported pain severity (Total Quality Pain Management survey) were recorded. RESULTS: The proportion of subjects who required morphine and/or fentanyl injections was significantly (p=0.004) lower in Group B (10%) as compared with Group R (36%) and Group C (44%). On the basis of the log-rank test, the opioid-free survival rates were significantly greater in Group B as compared to Groups C and R. Total opioid consumption (morphine equivalent mg/kg) in the first seventy-two hours postoperatively was significantly less in Group B as compared with Group C (mean difference, 0.225; [95% confidence interval (CI), 0.0152 to 0.435]; p=0.036). Parent-reported pain scores were also significantly lower in Group B as compared with both Group C (mean difference, 1.81 [95% CI, 0.38 to 3.25]; p=0.014) and Group R (mean difference, 1.66; 95% CI, 0.20 to 3.12; p=0.027). There were no significant differences across the three groups in terms of self-reported pain. Differences between Groups R and C were not significant for any of the outcome variables. CONCLUSIONS: The intra-articular injection of 0.25% bupivacaine significantly improves postoperative pain control following the closed reduction and percutaneous pinning of supracondylar humeral fractures in pediatric patients.
RCT Entities:
BACKGROUND: The purpose of this single-blinded, randomized, controlled trial was to compare the analgesic efficacy of intra-articular injections of bupivacaine or ropivacaine with that of no injection for postoperative pain control after the operative treatment of supracondylar humeral fractures in a pediatric population. METHODS: Subjects (n=124) were randomized to treatment with 0.25% bupivacaine (Group B) (n=42), 0.20% ropivacaine (Group R) (n=39), or no injection (Group C) (n=43). The opioid doses and the times of administration as well as child-reported pain severity (Faces Pain Scale-Revised) and parent-reported pain severity (Total Quality Pain Management survey) were recorded. RESULTS: The proportion of subjects who required morphine and/or fentanyl injections was significantly (p=0.004) lower in Group B (10%) as compared with Group R (36%) and Group C (44%). On the basis of the log-rank test, the opioid-free survival rates were significantly greater in Group B as compared to Groups C and R. Total opioid consumption (morphine equivalent mg/kg) in the first seventy-two hours postoperatively was significantly less in Group B as compared with Group C (mean difference, 0.225; [95% confidence interval (CI), 0.0152 to 0.435]; p=0.036). Parent-reported pain scores were also significantly lower in Group B as compared with both Group C (mean difference, 1.81 [95% CI, 0.38 to 3.25]; p=0.014) and Group R (mean difference, 1.66; 95% CI, 0.20 to 3.12; p=0.027). There were no significant differences across the three groups in terms of self-reported pain. Differences between Groups R and C were not significant for any of the outcome variables. CONCLUSIONS: The intra-articular injection of 0.25% bupivacaine significantly improves postoperative pain control following the closed reduction and percutaneous pinning of supracondylar humeral fractures in pediatric patients.
Authors: Ian K Y Lo; Paul Sciore; May Chung; Sherri Liang; Richard B Boorman; Gail M Thornton; Jerome B Rattner; Kenneth Muldrew Journal: Arthroscopy Date: 2009-07 Impact factor: 4.772
Authors: K Morgenthaler; C Bauer; S Ziegeler; T Mencke; M Werth; R Seil; M Dienst; S Soltész; M Silomon Journal: Anaesthesist Date: 2007-11 Impact factor: 1.041
Authors: Philippe Cuvillon; Emmanuel Nouvellon; Jacques Ripart; Jean-Christophe Boyer; Laurence Dehour; Aba Mahamat; Joel L'hermite; Christophe Boisson; Nathalie Vialles; Jean Yves Lefrant; Jean Emmanuel de La Coussaye Journal: Anesth Analg Date: 2009-02 Impact factor: 5.108
Authors: Bob Yin; David Levy; Molly Meadows; Todd Moen; Prakash Gorroochurn; Edwin R Cadet; William N Levine; Christopher S Ahmad Journal: Clin Orthop Relat Res Date: 2014-08 Impact factor: 4.176
Authors: Eric Astacio; Gabriel Echegaray; Lenny Rivera; Jorge M Otero-Delgado; Gerardo Olivella; Norman Ramírez; Nestor Ramos-Alconini; Christian Foy Journal: J Hand Surg Glob Online Date: 2020-03-21